We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Eidogen-Sertanty Licenses Discovery Informatics Software and Databases to Cephalon

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Eidogen-Sertanty, Inc. has announced that Cephalon, Inc. will access Eidogen-Sertanty's Kinase Knowledgebase (KKB™), Target Informatics Platform™ (TIP™), and EVE™ Comparative Visualization software.

Scientists at Cephalon will use the proprietary software to support small molecule drug discovery projects in their neurology and oncology therapeutic programs.

"We are pleased to provide Cephalon with broad access to several of our discovery informatics products," said Dr. Steve Muskal, CEO of Eidogen-Sertanty.

"We're confident that our kinase informatics and structural informatics solutions will help the experienced research team at Cephalon accelerate their lead discovery efforts."